drugset / Trial / NCT00584012

A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer

NCT00584012

Phase 1 Terminated 9 enrolled Susan L Roeder
NaSingle-groupOpen-labelTreatment

Summary

This purpose of this study is to evaluate the use of two medications, docetaxel and lovastatin to determine the highest dose of lovastatin and docetaxel that can be given safely as well as the safety of combining the two drugs and the effect on the subject's tumor. Subjects can have any cancer.

Timeline

Start
2004-04
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule Intravenous
Subject Lovastatin Small molecule Oral